The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvingtrans Regulatory News (AVG)

Share Price Information for Avingtrans (AVG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 425.00
Bid: 420.00
Ask: 430.00
Change: 0.00 (0.00%)
Spread: 10.00 (2.381%)
Open: 425.00
High: 425.00
Low: 425.00
Prev. Close: 425.00
AVG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Adaptix secures 510(k) clearance from FDA

30 Jan 2023 07:00

RNS Number : 1744O
Avingtrans PLC
30 January 2023
 

30 January 2023

Avingtrans Plc

 

("Avingtrans" or the "Group")

 

Adaptix secures 510(k) clearance from FDA

 

Avingtrans PLC (AIM: AVG), which designs, manufactures and supplies critical components, modules, systems and associated services to the energy, medical and industrial sectors, announces that medical imaging technology associate company Adaptix Limited (Adaptix) has received 510(k) clearance from the U.S. Food and Drug Administration for its first orthopaedic medical imaging product.

 

In 2021, Avingtrans invested £4m in Adaptix, for an 11.9% stake in the business and in December 2022 announced a further investment of £2m by means of a Convertible Loan.

 

The Board of Adaptix has made the following announcement:

 

Adaptix, based at Oxford University Science Park, has received 510(k) clearance for its first medical imaging product. The first Adaptix medical product is a Digital Tomosynthesis Orthopaedic imaging system. It is a portable, low-dose imaging system capable of delivering fast, lower-cost, X-ray imaging at the point of patient care. Developed specifically to offer 3D X-ray imaging of hands, elbows and feet at a fraction of the radiation dose and per-study price of traditional CT systems, the system provides clinicians with clearer images than 2D X-ray systems, offering advantages in terms of fewer acquisitions, accelerated patient workflow and enhanced diagnostic accuracy.

 

Adaptix is already serving veterinary and industrial (Non-Destructive Evaluation) markets using its novel and patent-protected technologies. Receiving the 510(k) clearance is important as it is the first step in Adaptix delivering its mission to transform radiology through provision of innovative truly-portable 3D imaging technologies into healthcare providers.

 

Mark Evans, CEO of Adaptix, commented:

 

"We are delighted to receive the 510(k) clearance which allows this innovative technology, and our first medical product, to be marketed in the world's largest healthcare market. The team are energized by achieving this milestone, and we look forward to delivering enhanced orthopaedic DT imaging systems; a dental DT imaging system; and a chest DT imaging system for Intensive Care and Emergency Department use. We see a future where 3D travels to the patient at the point-of-care throughout hospitals, clinics and primary care transforming patient pathways, improving patient experience, and reducing the cost of care delivery."

 

Enquiries:

 

Avingtrans plc

Roger McDowell, Chairman

Steve McQuillan, Chief Executive Officer

Stephen King, Chief Financial Officer

 

01354 692391

Singer Capital Markets (Nominated Adviser and Broker)

Shaun Dobson

Alex Bond

Oliver Platts

 

02074 963000

IFC Advisory (Financial PR)

Graham Herring

Tim Metcalfe

Zach Cohen

020 3934 6630

About Avingtrans plc: 

 

Avingtrans designs, manufactures and supplies original equipment, systems and associated aftermarket services to the energy, medical and industrial markets worldwide. 

 

Business units

 

Hayward Tyler - Luton & East Kilbride, UK and USA, China and India

 

Specialises in the design, manufacture and servicing of performance-critical motors and pumps for challenging environments.

 

Energy Steel, Inc - Rochester Hills, Michigan, USA

 

Energy Steel, part of the Engineered Pumps and Motors Division of Avingtrans plc, has been serving the nuclear power industry since 1982 with capabilities in equipment fabrication, material supply, precision machining, engineering, and repair services. Through strategic OEM partnerships, it also provides solutions for obsolete nuclear components and support for the most complex projects. 

 

Stainless Metalcraft Ltd - Chatteris, UK and Chengdu, China

 

Provider of safety-critical equipment for the energy, medical, science and research communities, worldwide, specialising in precision pressure and vacuum vessels and associated fabrications, sub-assemblies and systems.

 

Booth Industries - Bolton, UK

 

Designs, manufactures, installs and services doors and walls which can be tailored to be: blast &explosion proof; fireproof; acoustically shielded; high security/safety; or combinations of the above

 

Ormandy Group, Bradford, UK

 

Design, manufactures and servicing of off-site plant, heat exchangers and other HVAC (heating, ventilation and air conditioning) products

 

Composite Products Ltd - Buckingham, UK

 

Centre for composite technology, parts and assemblies, serving customers in industrial markets.

 

Magnetica Ltd - Brisbane, Australia

 

Magnetica Limited specialises in the development of next generation MRI technologies, including dedicated extremity MRI systems and MRI system components. Magnetica has successfully built and tested a compact, integrated 3 Tesla orthopaedic MRI system, demonstrating clinical-quality imaging. Commercialisation of this system (and others) is on-going. Magnetica's structure now includes two other business units:

 

Scientific Magnetics - Abingdon, UK

 

Designs and manufactures superconducting magnet systems and associated cryogenics for a variety of markets including MRI and provides services for Nuclear Magnetic Resonance instruments. 

 

Tecmag Inc, Houston, USA

 

Designs, manufactures and installs instrumentation, including consoles, system upgrades, and probes, mainly for Magnetic Resonance Imaging (MRI) and Nuclear Magnetic Resonance (NMR) systems.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAQKLFLXFLZBBE
Date   Source Headline
20th Oct 20083:21 pmRNSHolding(s) in Company
17th Oct 20081:37 pmRNSHolding(s) in Company
16th Oct 200811:06 amPRNResult of AGM and EGM
7th Oct 20087:00 amRNSRe Board Appointment
17th Sep 20087:00 amRNSIssue of Equity
10th Sep 20087:00 amPRNFinal Results
3rd Sep 20087:00 amPRNNotice of Results
2nd Sep 20087:00 amPRNMajor Contract Win with Rolls-Royce
19th Aug 20087:00 amPRNBoard Appointment
4th Jul 20081:06 pmRNSHolding(s) in Company
24th Apr 20084:35 pmRNSDirectorate Change
28th Mar 20083:16 pmRNSHolding(s) in Company
28th Mar 20083:12 pmRNSHolding(s) in Company
10th Mar 20085:30 pmRNSBoard composition
27th Feb 20087:00 amRNSInterim Results
22nd Feb 200810:52 amRNSAppointment of Director
28th Jan 20084:56 pmRNSHolding(s) in Company
25th Jan 20083:16 pmRNSHolding(s) in Company
23rd Jan 20081:01 pmRNSHolding(s) in Company
23rd Jan 20081:00 pmRNSHolding(s) in Company
16th Jan 200811:41 amPRNRe Contract
2nd Jan 20084:23 pmRNSHolding(s) in Company
20th Dec 20075:22 pmRNSDirector/PDMR Shareholding
18th Dec 20072:46 pmRNSTrading Statement
13th Nov 20073:44 pmRNSAdditional Listing
7th Nov 20074:06 pmRNSAnnual Report and Accounts
19th Oct 20073:43 pmPRNAGM Statement
11th Oct 200712:19 pmRNSHolding(s) in Company
13th Sep 20072:55 pmRNSHolding(s) in Company
13th Sep 20077:00 amPRNFinal Results
14th Aug 20072:41 pmRNSAIM Rule 26 Compliance
24th Jul 20071:18 pmRNSDirector Declaration -Amendmt
23rd Jul 20075:24 pmRNSDirector Declaration
7th Jun 200710:59 amPRNInvestment & Trading Update
1st Jun 200710:46 amRNSHolding(s) in Company
31st May 20077:00 amRNSTotal Voting Rights
17th May 20074:58 pmRNSHolding(s) in Company
10th May 20077:01 amRNSDirector/PDMR Shareholding
2nd May 20072:47 pmRNSHolding(s) in Company
2nd May 20077:10 amRNSTrading Statement
1st May 20073:14 pmRNSHolding(s) in Company
20th Apr 200710:56 amRNSHolding(s) in Company
22nd Mar 20079:49 amRNSHolding(s) in Company
22nd Mar 20079:46 amRNSHolding(s) in Company
9th Mar 200712:00 pmRNSHolding(s) in Company
7th Mar 20073:43 pmRNSHolding(s) in Company
21st Feb 20077:00 amPRNInterim Results
6th Feb 20075:20 pmRNSHolding(s) in Company
1st Feb 20077:00 amRNSChange of Adviser
4th Jan 20077:00 amPRNTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.